Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedAdvisor Limited ( (AU:MDR) ) has issued an update.
MedAdvisor Limited announced the cessation of Jim Xenos as a director, effective from August 29, 2025. This change in the board may impact the company’s strategic direction and stakeholder relations, given Mr. Xenos’s significant interests in the company, including 42,857 fully paid ordinary shares and 500,000 unlisted options.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, focusing on providing digital medication management solutions. The company offers services that help patients manage their medication schedules and improve adherence, targeting both individual users and healthcare providers.
Average Trading Volume: 994,393
Technical Sentiment Signal: Sell
Current Market Cap: A$32.51M
Learn more about MDR stock on TipRanks’ Stock Analysis page.